Selective D1 and D2 dopamine receptor antagonists produce differential effects on reaction time in the rat. 1993

R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
Department of Kinesiology, University of Texas at Austin 78712.

The purpose of this investigation was to determine whether selectively blocking D1 and D2 dopamine receptors produces a differential effect on the characteristics (speed and success) of the reaction time response in rats. Animals were shaped to release a lever in response to an auditory/visual stimulus to avoid mild foot shock. The selective D1 antagonist SCH 23390 (0, 70, and 100 micrograms/kg, IP) and the selective D2 antagonists spiperone (0, 1, and 10 micrograms/kg, IP) and haloperidol (0, 10, and 100 micrograms/kg, IP) were studied for their effects on successful avoidance and response latency. SCH 23390 impaired successful avoidance and increased response latencies in a dose-dependent manner. Spiperone and haloperidol also produced dose-related decreases in successful avoidance. In contrast to the dose-related increase in response latencies produced by SCH 23990, 1 microgram/kg spiperone and 10 micrograms/kg haloperidol significantly decreased the latencies of successful responses. Spiperone (10 micrograms/kg) had little effect on response latencies, while 100 micrograms/kg haloperidol increased them. The results of these experiments demonstrate that reaction time is differentially affected by selective dopamine receptor blockade and that the speed and success of reaction time responses can be independently modulated by D1 vs. D2 receptor activity.

UI MeSH Term Description Entries
D008297 Male Males
D010775 Photic Stimulation Investigative technique commonly used during ELECTROENCEPHALOGRAPHY in which a series of bright light flashes or visual patterns are used to elicit brain activity. Stimulation, Photic,Visual Stimulation,Photic Stimulations,Stimulation, Visual,Stimulations, Photic,Stimulations, Visual,Visual Stimulations
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D000161 Acoustic Stimulation Use of sound to elicit a response in the nervous system. Auditory Stimulation,Stimulation, Acoustic,Stimulation, Auditory
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D013134 Spiperone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA. Spiroperidol,Spiroperone

Related Publications

R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
December 2006, Behavioural brain research,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
January 1989, Psychopharmacology series,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
December 2003, The Chinese journal of physiology,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
December 2003, Behavioural pharmacology,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
October 1990, Experientia,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
August 2009, Journal of neurophysiology,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
January 1991, Psychopharmacology,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
September 2010, Neuroscience,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
September 1989, Pharmacology, biochemistry, and behavior,
R D Mayfield, and P K Randall, and W W Spirduso, and R E Wilcox
September 1991, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!